Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity
- 1 June 2016
- journal article
- review article
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 14 (6) , 23-29
Abstract
Review question/objective: The objective of this review is to examine the current best available evidence on the effectiveness of botulinum toxin type A on gait (velocity and distance) and quality of life (QoL) in adult post-stroke patients with lower limb spasticity. More specifically, this review aims to determine the effectiveness of botulinum toxin type A on adult post-stroke patients with lower limb spasticity in relation to: Gait velocity Walking distance QoL.Keywords
This publication has 9 references indexed in Scilit:
- Toward an epidemiology of poststroke spasticityNeurology, 2013
- The global burden of stroke and need for a continuum of careNeurology, 2013
- Evidence to Practice: Botulinum Toxin in the Treatment of Spasticity Post StrokeTopics in Stroke Rehabilitation, 2012
- European consensus table on the use of botulinum toxin type A in adult spasticityJournal of Rehabilitation Medicine, 2009
- Botulinum toxin should be first-line treatment for poststroke spasticityJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Effect of Simultaneous Botulinum Toxin Injections Into Several Muscles on Impairment, Activity, Participation, and Quality of Life Among Stroke Patients Presenting With a Stiff Knee GaitStroke, 2008
- Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticityJournal of Neural Transmission, 2008
- Oral antispastic drugs in nonprogressive neurologic diseasesNeurology, 2004
- Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a StrokeNew England Journal of Medicine, 2002